Compare Vanguard Intermediate Term Corporate Bond ETF (VCIT) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vanguard Intermediate Term Corporate Bond ETF vs 22nd Century Group Inc — how do they compare? Vanguard Intermediate Term Corporate Bond ETF trades at $81.21, while 22nd Century Group Inc trades at $4.38 (market cap $1.52M). Which is the better fit depends on your goals.
| VCIT | XXII | |
|---|---|---|
Sector | Fixed Income | Technology |
52-Week High | $84.82 | $801.00 |
52-Week Low | $81.07 | $3.72 |
Market Cap | — | $1.52M |
Enterprise Value | — | -$6.71M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
VCIT, the Vanguard Intermediate-Term Corporate Bond ETF, trades at $81.225 with a modest 0.19% daily gain. Technical indicators show a bearish trend with moving averages signaling sell pressure, though oscillators remain neutral. The ETF maintains consistent monthly dividend distributions, with recent payments of $0.34 and $0.33. Recent financial media coverage highlights VCIT's competitive 0.03% expense ratio and approximately 5% yield compared to similar bond ETFs.
The outlook for VCIT remains balanced with income generation as the primary appeal, though technical weakness suggests near-term pressure. Investment opportunities include attractive yield relative to Treasury alternatives and low expense structure. Risks include interest rate sensitivity and corporate credit quality concerns in changing economic conditions.
XXII trades at $4.46, up 2.53% today, with a neutral technical signal and bearish moving averages. The company shows deep losses with a net income margin of -65.76% and negative ROE of -130.19%, though it beat earnings in Q3 2025. Recent news highlights VLN® retail expansion in California and New York, and a reverse stock split on June 12, 2026. Cash flow remains dependent on financing, with operating cash flow negative at -$7.72 million in 2025.
Outlook is speculative; analyst consensus is 75% buy with growth potential from VLN® market expansion, but high execution and regulatory risks persist. Investment hinges on revenue scaling to offset persistent losses, with stock volatility expected near key resistance at $5.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Vanguard Intermediate Term Corporate Bond ETF
VCIT tracks the Bloomberg U.S. 5-10 Year Corporate Bond Index, providing exposure to investment-grade debt from industrial, utility, and financial companies. It acts as a middle-ground bond fund, offering higher yields than short-term bonds with less price volatility than long-term corporate debt.
Read more on VCIT →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
